API Under Development

API Under Development encompasses Cetrizine Hydrochloride IP-BP-USP and Empagliflozin IP-BP-USP, among others. Cetrizine Hydrochloride, an antihistamine, with the chemical formula C21H25ClN2O3, lacks odor and presents as a powder. Empagliflozin, indicated for type 2 diabetes, holds the formula C23H27ClO7 and is also odorless in powder form. These APIs are in the industrial grade and stored at room temperature. Formulation involves integrating them with excipients for various applications. Testing evaluates their purity and efficacy. The effects of these APIs are tailored to their therapeutic purposes, ensuring safety and potency for commercial use, once development completes.